GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (BOM:543329) » Definitions » Construction In Progress

Windlas Biotech (BOM:543329) Construction In Progress : ₹32 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech Construction In Progress?

Windlas Biotech's quarterly construction in progress declined from Sep. 2024 (₹315 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹32 Mil).

Windlas Biotech's annual construction in progress declined from Mar. 2023 (₹526 Mil) to Mar. 2024 (₹105 Mil) and declined from Mar. 2024 (₹105 Mil) to Mar. 2025 (₹32 Mil).


Windlas Biotech Construction In Progress Historical Data

The historical data trend for Windlas Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech Construction In Progress Chart

Windlas Biotech Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Construction In Progress
Get a 7-Day Free Trial 2.10 77.34 525.72 105.40 32.01

Windlas Biotech Quarterly Data
Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.40 - 314.74 - 32.01

Windlas Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Windlas Biotech Business Description

Traded in Other Exchanges
Address
Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech Headlines

No Headlines